Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials

BACKGROUND: Although the current consensus recommends a standard treatment of high-dose intravenous immunoglobulin with high-dose aspirin to manage Kawasaki disease (KD), the use of different adjunctive therapies remains controversial. The aim of the current network meta-analysis (NMA) was to compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Wei-Te, Chang, Ling-Sai, Zeng, Bing-Yan, Tu, Yu-Kang, Uehara, Ritei, Matsuoka, Yutaka J., Su, Kuan-Pin, Lee, Pi-Chang, Cavalcante, Joao L., Stubbs, Brendon, Lin, Pao-Yen, Wu, Yi-Cheng, Hsu, Chih-Wei, Chen, Tien-Yu, Chen, Yen-Wen, Yeh, Pin-Yang, Sun, Cheuk-Kwan, Tseng, Ping-Tao, Kao, Yu-Hsuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933672/
https://www.ncbi.nlm.nih.gov/pubmed/35306339
http://dx.doi.org/10.1016/j.ebiom.2022.103946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933672/
https://www.ncbi.nlm.nih.gov/pubmed/35306339
http://dx.doi.org/10.1016/j.ebiom.2022.103946

Ejemplares similares